Archbishop Stepinac High School, in White Plains, N.Y., is one of the first schools in the U.S. to do away with paper textbooks. Instead, the all-boys prep school requires students to use tablets and laptops in class. (Data provided by Statista.com.)
NYS Entity Status
NYS Filing Date
APRIL 24, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - J&J TRIREME GLOBAL, INC
AROUND THE WEB
- A High School Without Textbooks
Tuesday Oct 8, 2013
- WGN America Lands Crime Dramas ‘100 Code,’ ‘Pure’ and ‘Shoot the Messenger’
By Tim Molloy, provided by
- Tuesday Aug 8, 2017
The network has secured the U.S. rights for three crime-focused shows — “100 Code,” “Shoot the Messenger,” and “Pure” — which will join the previously announced Anna Paquin-fronted “Bellevue” to add to the network’s stash of “primecrime” programming.When a high school hockey star wrestling with his gender identity goes missing and all signs point to foul play, Detective Annie Ryder (Anna Paquin) must unravel all the pieces to this gripping mystery before her own life falls apart.A gritty political-crime thriller centering on the complex relationships between crime reporters and the police, “Shoot the Messenger” follows Daisy Channing (Elyse Levesque), a young reporter trying to balance a messy personal life with a burgeoning career. Things begin to go sideways for Daisy when she witnesses a murder she thinks is gang related, only to find herself slowly drawn into an interconnected web of criminal and illicit sexual activity that reaches into the corridors of corporate and political power.With help from her editor Mary Foster (Alex Kingston), co-worker Simon Olenski (Lucas Bryant), and lead homicide detective Kevin Lutz (Lyriq Bent), Daisy uncovers a cover-up so scandalous it could bring down the government.“Shoot the Messenger” is produced by Jennifer Holness and Victoria Woods for Hungry Eyes Film & Television Inc. in association with CBC Television and ITV Studios Global Entertainment.Inspired by true events, “Pure” is the journey of Noah Funk-newly elected Mennonite pastor-who is determined to rid his community of the scourge of drugs and its nefarious ties to a transborder smuggling alliance with ruthless Mexican cocaine cartels. NY, “Justified” as Detective Bronco Novak; and Oscar and Golden Globe Nominee Rosie Perez (“Search Party,” White Men Can’t Jump) as DEA Agent Phoebe O’Reilly.Developed by Academy Award winner Bobby Moresco (Crash, Million Dollar Baby), “100 Code” stars Dominic Monaghan (“Lost,” Lord of the Rings Trilogy) as New York Detective Tommy Conley and the late Michael Nyqvist (John Wick, The Girl with the Dragon Tattoo) as the by-the-book Swedish detective Mikael Eklund.
- biosimilar drugs can be a hard sell
By Jared S. Hopkins - Tuesday Aug 15, 2017
Part of the problem: a web of relationships between drug companies and insurers that shields incumbent drugs and often sidelines upstarts until the market becomes crowded.Pfizer said this month that Inflectra, its version of the blockbuster Johnson & Johnson rheumatoid arthritis drug Remicade, brought in $94 million in the second quarter.J&J spokeswoman Caroline Pavis said in a statement that Remicade is sold in a highly competitive market and that health plans decide on coverage.Doctors and patients tend to be loyal to innovative drugs that have worked well, payers are cautious in adopting alternatives, and Biosimilars can’t be swapped at the pharmacy because they aren’t identical to the drugs they are designed to replace.Remicade, known as infliximab and approved in the U.S. in 1998 for treating the digestive disorder Crohn’s disease, was cleared for rheumatoid arthritis a year later.J&J has exclusive contracts in nearly half its market, according to analyst Ronny Gal of Sanford Bernstein & Co., meaning payers agree to cover only Remicade for rheumatoid arthritis.When Sandoz released white-blood-cell booster Zarxio, the first biosimilar approved in the U.S., two years ago, it cost 15 percent less than Amgen’s Neupogen.[...] Neupogen has gradually lost its dominance, with sales sliding from $1.4 billion in 2013 to $765 million last year.[...] another similar drug, Granix by Teva Pharmaceutical, has been cleared, and Express Scripts last week became the second pharmacy-benefit manager to exclude Neupogen from its list of covered medicines.[...] Kay’s hospital found Inflectra cost $25 more than Remicade a vial, a discrepancy he attributes to pricing negotiations involving the supply chain.Makers of name-brand drugs once opposed biosimilars, citing safety among other concerns, but now say they have the manufacturing muscle and experience to produce and distribute the drugs.“For 20 years, until maybe this year, the brand industry’s position was, ‘Don’t take a biosimilar, it’s scary, it’s dangerous,’” said Bruce Leicher, senior vice president and general counsel at Momenta Pharmaceuticals, which sells generics and is developing Biosimilars.
- Could the Rockaways Survive Another Sandy?
By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017
Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."